Chinook Therapeutics Presents Data from Atrasentan Phase 2
The AFFINITY IgAN cohort of 20 patients is fully enrolled, with 70% of patients in the study having baseline proteinuria over one gram per day despite...
Source: globenewswire.com
Page 7 - Eric Dobmeier News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric Dobmeier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Dobmeier Today - Breaking & Trending Today
Chinook Therapeutics Presents Updated Data from BION-1301
All patients with IgAN in Cohort 1 have transitioned to subcutaneous (SC) dosing, and BION-1301 remains well-tolerated, with no serious adverse events...
Source: globenewswire.com
Chinook Therapeutics Announces Appointment of Dr. Mahesh
SEATTLE, March 21, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development...
Source: globenewswire.com
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Chinook Therapeutics Provides Business Update and Reports
SEATTLE, March 17, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...
Source: globenewswire.com